Hook and thesis
Berkshire Hathaway (BRK.A) is a different kind of buy-and-hold story in 2026: it carries both optionality and scale. The company sits on a record $397 billion of cash and equivalents while trading at a reasonable P/E of 15.3 and a price-to-book of roughly 1.42. Management has already dipped a toe into repurchases with a $234 million purchase by CEO Greg Abel on 05/04/2026 - the first buyback in 21 months - and that action is a concrete signal that capital deployment could accelerate.
My thesis: buy BRK.A now at $710,300.30 and position ahead of larger buybacks or M&A. The trade is designed to capture the re-rating that follows purposeful capital deployment from an unusually large cash horde, while using a tight stop to limit downside if the market or management disappoints.
Why the market should care - business in one paragraph
Berkshire is a diversified conglomerate with exposure to insurance underwriting and float, BNSF freight rail, Berkshire Hathaway Energy utilities, manufacturing, distribution, and retailing. Those operating businesses generate predictable cash flow - free cash flow was $25.04 billion most recently - while the insurance float and investment portfolio give Berkshire the capital to act opportunistically. With a low debt-to-equity ratio (~0.18) and strong liquidity, Berkshire is positioned to use its balance sheet to buy assets or return capital in ways that move intrinsic value materially.
Supporting data and valuation framing
Key numbers underpin the case:
- Share price: $710,300.30.
- Market capitalization: ~$1.02 trillion.
- Enterprise value: ~$1.099 trillion.
- P/E: 15.25; P/B: 1.42.
- Free cash flow (most recent): $25.042 billion.
- Cash pile reported: $397 billion (reported 05/04/2026).
- Return on equity: 9.33%; return on assets: 5.48%.
The combination of a sub-16 P/E and only a modest premium to book (1.4x) is notable for a company with a fortress balance sheet and multiple durable cash engines. Historically, Berkshire trades at material premiums to book during frothy markets; the current P/B suggests a less stretched valuation than prior peaks (52-week high $812,855). In plain terms: you get a conservative conglomerate with an extraordinary optionality kicker for a reasonable multiple.
Quick valuation summary (table)
| Metric | Value |
|---|---|
| Share price | $710,300.30 |
| Market cap | $1.02T |
| P/E | 15.25 |
| P/B | 1.42 |
| Free cash flow | $25.04B |
| Reported cash | $397B |
Catalysts
- Active capital deployment - buybacks and M&A: The March-April purchases and the $234 million repurchase on 05/04/2026 show a willingness to buy shares at current valuation bands. If buybacks accelerate or management announces targeted M&A paid for in cash, the market will likely re-rate the stock higher.
- Market pullback that invites opportunistic purchases: Berkshire historically steps in when valuations across the market fall. Any sizable S&P retraction could trigger significant stock purchases given the cash cushion.
- Operating performance stabilization: steady free cash flow from utilities, rail (BNSF), and insurance underwriting could widen margins or accelerate buybacks financed by operating cash, not just liquid assets.
- Reassuring capital allocation by Greg Abel: early moves that mirror Buffett's discipline but with faster execution could boost investor confidence and compress the valuation gap relative to intrinsic value.
Trade plan (actionable)
Trade direction: Long
Entry price: $710,300.30
Target price: $795,000.00
Stop loss: $680,000.00
Time horizon: position (180 trading days). I expect the move to play out over multiple quarters — the window is driven by the cadence of capital deployment (announcements, incremental buybacks or a deal) and operational reporting cycles. A 180-trading-day horizon gives time for management to act and for the market to re-rate results and capital allocation.
Rationale for the specific levels: the entry is the current tape. The stop at $680,000 limits downside to approximately 4% and sits below recent 52-week low territory of $685,150, providing a technical cushion. The $795,000 target represents roughly a 12% upside tied to re-rating toward prior trading premiums and modest multiple expansion if buybacks or M&A begin in earnest.
Technical and liquidity notes
Technicals are neutral-to-constructive: the 10-day SMA (~$708,926) and 9-day EMA (~$710,762) are close to price, while momentum indicators show a bullish MACD histogram. Average volumes are small in absolute terms given the A share class, and short interest is low with days to cover near 1, which limits the chance of a short-squeeze driven spike but also suggests a calm base rather than speculative flows.
Risks & counterarguments
Every trade has risks. I outline the main ones below and include a direct counterargument to the bullish thesis.
- Valuation and macro shock: If the S&P 500 or credit markets suffer a deep correction, Berkshire could face paper losses across its equity portfolio and delay buybacks or M&A. The recent article noting a CAPE of 40.1 reminds us market valuations remain vulnerable.
- Cash deployment that destroys value: A large, poorly priced acquisition or a rush into low-return assets would compress returns and justify a lower multiple. Berkshire's hallmark has been disciplined deals; a change in approach would be negative.
- Insurance underwriting volatility: Berkshire's insurance operations can swing from being an advantage to a headwind if underwriting losses rise materially, which would reduce the available float and operating cash flow.
- Execution under new CEO: Greg Abel is early in his tenure. While his initial moves are conservative, any strategic missteps or slower-than-expected capital deployment could disappoint investors and keep the stock range-bound.
- Opportunity cost and buyback signaling: The initial $234M repurchase is small relative to $397B cash. If the market interprets continued small or symbolic buybacks as a sign management is too cautious, the re-rate may not occur.
Counterargument
A strong counterargument is simple: management will do nothing with the cash. If Greg Abel and the board choose patience — preferring to hold the $397B as a strategic reserve — there is limited near-term upside. In that scenario the stock could grind sideways or lag the market despite strong operating cash flow. That outcome would punish patience-dependent shareholders and make the trade ineffective over the planned horizon.
What would change my mind
I would reduce conviction or flip to neutral/short if any of the following occurs: management announces they will keep cash parked with no intention to buy back shares or pursue M&A for the next 12-18 months; a major acquisition is announced at an obviously dilutive multiple; material deterioration in insurance underwriting; or macro stress that forces the company to mark-to-market large equity stakes and show meaningful losses. Conversely, an acceleration in buybacks or a high-quality acquisition funded from cash would increase my conviction.
Conclusion
This is a pragmatic, event-driven long: the setup is simple — conservative valuation, strong free cash flow, an unusually large cash reserve and early signs of capital deployment. The reward is a re-rating or outright increase in intrinsic value should buybacks or M&A materialize. The risk is management inaction or a macro shock that forces reactive capital decisions. With a defined entry, stop and target, the trade lets you participate in the upside while capping downside exposure.
Key points (quick checklist)
- Entry: $710,300.30
- Target: $795,000.00
- Stop: $680,000.00
- Horizon: position (180 trading days)
- Core thesis: buy before meaningful deployment of a $397B cash pile, which should catalyze a re-rating if executed properly.